Hi Urche
I guess I have mixed feelings about the announcement. No upfront cash which is bad because they will need money but Roche certainly wants to be a player in this market so thats a big plus.
As far as people buying the stock based on the empty press release I believe it was based on the fact that RBM said they were going to get a large partner to distribute their product.. and they did as they said.
They said they would get the flu test approved and they did.
They said the NT-Pro-BNP approval will come after the parter.. guaranteed to happen now
I find it interesting that Roche abandoned their own POC test in favor of RBM's.
I guess I have mixed feelings about the announcement. No upfront cash which is bad because they will need money but Roche certainly wants to be a player in this market so thats a big plus.
As far as people buying the stock based on the empty press release I believe it was based on the fact that RBM said they were going to get a large partner to distribute their product.. and they did as they said.
They said they would get the flu test approved and they did.
They said the NT-Pro-BNP approval will come after the parter.. guaranteed to happen now
I find it interesting that Roche abandoned their own POC test in favor of RBM's.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
